Titel: An individual dosing strategy for intravenous colistin associated with a low risk of nephrotoxicity
Auteur(s): HJM van Kan, AG Otten-Helmers, BCP Koch, M Bakker, BJA Rijnders, ARH van Zanten, M van Westreenen, LAA van Gendt-de Jong, on behalf of the COLIGO consortium.
Publicatiedatum: 24-04-2018
Titel: Is higher dosing of intravenous colistin required in cystic fibrosis patients?
Auteur(s): HJM van Kan, AG Otten-Helmers, LAA van Gendt-de Jong, BCP Koch, ARH van Zanten, BJA Rijnders, MM van der Eerden, RAS Hoek, M van Westreenen, M Bakker
Publicatiedatum: 23-04-2017
Titel: Variability of colistin plasma protein binding during intravenous treatment
Auteur(s): HJM van Kan, AG Otten-Helmers, E Olyslager, BCP Koch, ARH van Zanten, M van Westreenen, LAA van Gendt-de Jong
Publicatiedatum: 10-04-2016